LOHOCLA RESEARCH CORPORATION

Basic Information

12635 E. Montview Blvd.
AURORA, CO, 80045-7337

Company Profile

n/a

Additional Details

Field Value
DUNS: 966627499
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder

    Amount: $1,000,000.00

    DESCRIPTION provided by applicant Alcohol Use Disorder affects of the U S population ages and older and costs society over $ billion per year in direct medical costs accidents and lost ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Small Molecule Inhibitors of the BCL6 Oncoprotein

    Amount: $316,474.00

    DESCRIPTION (provided by applicant): Chronic pain syndromes affect 25-35% of populations around the world. The presence of chronic pain generates a massive toll on quality of life, workforce productiv ...

    SBIR Phase I 2013 Department of Health and Human Services
  3. Monoclonal antibody mediated biomarker discovery for alcohol-induced liver damage

    Amount: $240,065.00

    DESCRIPTION (provided by applicant): The goal of this SBIR application is to demonstrate the feasibility of a global approach to screen for disease specific monoclonal antibodies (mAbs) to low level p ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. Proteomic Markers of Alcohol Abuse (Phase 1)

    Amount: $1,344,880.00

    DESCRIPTION (provided by applicant): Alcohol dependence and hazardous levels of ethanol ingestion are under-diagnosed and under-reported. Significant effort has been expended to develop biological ma ...

    SBIR Phase II 2005 Department of Health and Human Services
  5. DEV OF CORRELATIONAL ALCOHOL-RELEVANT DATABASE

    Amount: $156,217.00

    N/A

    SBIR Phase I 2004 Department of Health and Human Services
  6. Proteomic Markers of Alcohol Abuse (Phase 1)

    Amount: $396,228.00

    DESCRIPTION (provided by applicant): Alcohol dependence and hazardous levels of ethanol ingestion are under-diagnosed and under-reported. Significant effort has been expended to develop biological ma ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. N/A

    Amount: $156,875.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  8. Medications for Alcohol Withdrawal/Brain Damage

    Amount: $748,637.00

    Chronic ethanol ingestion results in neurodegeneration with loss of neurons, glial proliferation anventricular and subarachnoid space. Work from our laboratories has demonstrated that chronic ethanola ...

    SBIR Phase II 1997 Department of Health and Human Services
  9. Medications for Alcohol Withdrawal/Brain Damage

    Amount: $78,375.00

    N/A

    SBIR Phase I 1995 Department of Health and Human Services
  10. THE APPLICATION'S LONG-TERM OBJECTIVE IS TO DEVELOP A MORE EFFECTIVE, SAFE, RELATIVELY LONG-TERM BARRIER CONTRACEPTIVE DEVICE.

    Amount: $45,800.00

    THE APPLICATION'S LONG-TERM OBJECTIVE IS TO DEVELOP A MORE EFFECTIVE, SAFE, RELATIVELY LONG-TERM BARRIER CONTRACEPTIVE DEVICE. DEVELOPMENT OF THE PROPOSED DEVICE WILL HAVE SIGNIFICANT IMPACT ON EFFECT ...

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government